Oxford-AstraZeneca vaccine 70% efficient

Tell a friend about this post

AstraZeneca and Oxford University have more work to do to confirm whether their COVID-19 vaccine can be 90 per cent effective, peer-reviewed data published in The Lancet showed on Tuesday, potentially slowing its eventual rollout in the fight against the pandemic.

Once seen as the frontrunner in the development of a vaccine against the coronavirus crisis, the British team were overtaken by U.S. drugmaker Pfizer, whose shots – with a success rate of around 95 per cent – were administered to UK pensioners on Tuesday in a world-first hailed as V-Day.


Oxford-AstraZeneca vaccine shows 70% overall efficacy, more work needed: study

Tell a friend about this post
READ ALSO  Sterling set to suffer from specter of London lockdown, Brexit…

You cannot copy content of this page